IVF Hartmann Holding AG (VBSN.SW) Stock Analysis & Winston Score
IVF Hartmann Holding AG is a Swiss healthcare company that makes medical supplies used in hospitals, clinics, and care homes. Its core products include wound care dressings, disinfectants, hygiene products, and incontinence supplies. The company sells mainly to healthcare professionals and institutions across Europe, with a strong heritage in the Swiss and German-speaking markets. The company earns revenue by selling consumable medical products, meaning customers need to reorder regularly, which creates a steady and predictable income stream. IVF Hartmann operates primarily in Central Europe and generates roughly $300 million in market value, competing in a fragmented but stable industry where brand trust and distribution relationships act as its main competitive advantages. The key risk is pricing pressure from lower-cost generic suppliers and larger global competitors, which could squeeze the company's already modest gross margins over time.
Winston Score: 63/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (15/30)
- Growth: Good (11/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (10/10)
- Valuation: Mixed (4/10)
- Ownership: Good (10/15)
Key Facts
Price: 136.00 CHF
Market Cap: 324M CHF
Sector: Healthcare
Industry: Medical - Specialties
Exchange: SIX Swiss Exchange

